Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1570 results found
2025 ∙ Thiyagarajan, G. Nagasubramanian, V. R. Ravichandran, S. L. Baskaran, P. Thangam, D. C. Sankaranarayanan, R. K. Undela, K. Sridevi, B. Pelluri, R. Gurram, P. C. Rajangam, J.
Acceptance and reluctance of COVID-19 vaccination among the general population: a systematic review and meta-analysis of cross-sectional studies
All age groups COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Min Htike, W. Y. Zhang, M. Wu, Z. Zhou, X. Lyu, S. Kam, Y. W.
Addressing Vaccine Hesitancy in College Students Post COVID-19 Pandemic: A Systematic Review Using COVID-19 as a Case Study
Adolescents Adults Older adults COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Coyne, B. M. Ito, D. Tariq, A. Lew, S. Q. Kopp, J. Vinales, P. C. Malik, F. Gipson, P. E. Nobakht, E.
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sadowski, J. Huk, J. Otulak, S. Zawilo, J. Klaudel, T. Roszak, M. Tenczynski, D. Buldak, R. J.
Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Maggi, S. Fulop, T. De Vita, E. Limongi, F. Pizzol, D. Di Gennaro, F. Veronese, N.
Association between vaccinations and risk of dementia: A systematic review and meta-analysis
Adults Older adults COVID-19 Herpes zoster Tetanus Diphtheria Pertussis Influenza Pneumococcal disease Poliomyelitis Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sanftenberg, L. Kraeker, L. Walter, F. Tsiligianni, I. Bouloukaki, I. Roos, M. Gensichen, J.
Associations between common mental disorders and vaccination readiness against seasonal influenza and Covid-19 of chronically ill adult patients in primary care - a systematic review
Adults Older adults COVID-19 Influenza Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Vink, K. Kusters, J. Wallinga, J.
Chrono-optimizing vaccine administration: a systematic review and meta-analysis
Adults Older adults COVID-19 Influenza Hepatitis B Hepatitis A Pneumococcal disease Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Boikos, C. Schaible, K. Nunez-Gonzalez, S. Welch, V. Hu, T. Kyaw, M. H. Choi, L. E. Kamar, J. Goebe, H. McLaughlin, J.
Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review
Adults Older adults COVID-19 Influenza Efficacy/effectiveness Safety Coverage Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Li, S. Li, R. Li, Y. Hu, Y. Liu, Y. Qin, J. Qin, Z. Feng, Q. Sheng, Z. Li, C. Peng, J.
Combination of Evans syndrome and COVID-19: a systematic review of reported cases
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...